Pamela B Allen

Trials

Studies that name Pamela B Allen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:00 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT04676087 · Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides

  Emory University · terminated · Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 04:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Microbial Drivers of Radiation Resistance and Large Cell Transformation in Mycosis Fungoides and Sezary Syndrome
  R21AI200485 · NIAID · EMORY UNIVERSITY · fiscal years 2026 · $234,750 awarded in 2026
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Winship Cancer Institute Cancer Center Support Grant
  P30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · fiscal years 2009 to 2026
  Named on NCT04676087